The influence of labour on the pharmacokinetics of intravenously administered amoxicillin in pregnant women

British Journal of Clinical Pharmacology

Volumn 66, Issue 6, 2008, Pages 866-874

  Muller, Anouk E ^a   Dörr, P Joep ^b   Mouton, Johan W ^c   De Jongh, Joost ^d,e   Oostvogel, Paul M ^b   Steegers, Eric A P ^a   Voskuyl, Rob A ^e   Danhof, Meindert ^e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^d LAP and P Consultants BV   (Netherlands)

^e LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Amoxicillin; Covariate analysis; Population pharmacokinetic modelling; Postpartum period; Uterine contractions

Indexed keywords

AMOXICILLIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; GESTATIONAL AGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LABOR; NEWBORN; NEWBORN INFECTION; NONLINEAR SYSTEM; PREGNANT WOMAN; PRIORITY JOURNAL; PUERPERIUM; STREPTOCOCCUS AGALACTIAE; UTERUS CONTRACTION;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; LABOR, OBSTETRIC; METABOLIC CLEARANCE RATE; PREGNANCY; PREGNANCY OUTCOME;

EID: 56549091300     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03292.x     Document Type: Article

References (39)

1. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group b streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002 51 (RR-11 1 22.
2. Bergseng H, Bevanger L, Rygg M, Bergh K. Real-time PCR targeting the sip gene for detection of group B Streptococcus colonization in pregnant women at delivery. J Med Microbiol 2007 56 : 223 8.
3. Brimil N, Barthell E, Heindrichs U, Kuhn M, Lutticken R, Spellerberg B. Epidemiology of Streptococcus agalactiae colonization in Germany. Int J Med Microbiol 2006 296 : 39 44.
4. Valkenburg-van den Berg AW, Sprij AJ, Oostvogel PM, Mutsaers JA, Renes WB, Rosendaal FR, Joep Dorr P. Prevalence of colonisation with group B Streptococci in pregnant women of a multi-ethnic population in The Netherlands. Eur J Obstet Gynecol Reprod Biol 2006 124 : 178 83.
5. Schuchat A, Wenger JD. Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development. Epidemiol Rev 1994 16 : 374 402.
6. Anderson GD. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 2005 44 : 989 1008.
7. Muller AE, DeJongh J, Oostvogel PM, Voskuyl RA, Dorr PJ, Danhof M, Mouton JW. Amoxicillin pharmacokinetics in pregnant women with preterm premature rupture of the membranes. Am J Obstet Gynecol 2008 198 : 108.e1 6.
8. Nation RL. Drug kinetics in childbirth. Clin Pharmacokinet 1980 5 : 340 64.
9. Beal SL, Sheiner LB, Boeckmann AJ. NONMEM Users Guides, (1989-2006). Ellicott City, MD : Icon Development Solutions, 2006.
10. Schoemaker RC, Cohen AF. Estimating impossible curves using NONMEM. Br J Clin Pharmacol 1996 42 : 283 90.
11. Liefaard LC, Ploeger BA, Molthoff CF, Boellaard R, Lammertsma AA, Danhof M, Voskuyl RA. Population pharmacokinetic analysis for simultaneous determination of B (max) and K (D) in vivo by positron emission tomography. Mol Imaging Biol 2005 7 : 411 21.
12. Maitre PO, Buhrer M, Thomson D, Stanski DR. A three-step approach combining Bayesian regression and NONMEM population analysis: application to midazolam. J Pharmacokinet Biopharm 1991 19 : 377 84.
13. Mandema JW, Verotta D, Sheiner LB. Building population pharmacokinetic - pharmacodynamic models. I. Models for covariate effects. J Pharmacokinet Biopharm 1992 20 : 511 28.
14. Sheiner BL, Beal SL. Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic data. J Pharmacokinet Biopharm 1981 9 : 635 51.
15. Bonate PL. Recommended reading in population pharmacokinetic pharmacodynamics. AAPS J 2005 7 : E363 73.
16. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976 16 : 31 41.
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 130 : 461 70.
18. Gabrielsson J, Weiner D. Pharmacokinetic concepts. In : Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts & Applications, 3rd edn, eds Gabrielsson J, Weiner D. Stockholm : Apothekarsocieteten, Swedisch Pharmaceutical Society, 2000 45 174.
19. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004 141 : 929 37.
20. Poggio ED, Wang X, Greene T, Van Lente F, Hall PM. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 2005 16 : 459 66.
21. Alper AB, Yi Y, Webber LS, Pridjian G, Mumuney AA, Saade G, Morgan J, Nuwayhid B, Belfort M, Puschett J. Estimation of glomerular filtration rate in preeclamptic patients. Am J Perinatol 2007 24 : 569 74.
22. Andrew MA, Easterling TR, Carr DB, Shen D, Buchanan ML, Rutherford T, Bennett R, Vicini P, Hebert MF. Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies. Clin Pharmacol Ther 2007 81 : 547 56.
23. Bray RE, Boe RW, Johnson WL. Transfer of ampicillin into fetus and amniotic fluid from maternal plasma in late pregnancy. Am J Obstet Gynecol 1966 96 : 938 42.
24. Voigt R, Schroder S, Meinhold P, Zenner I, Noschel H. Klinische Untersuchungen zum Einfluss von Schwangerschaft und Geburt auf die Pharmacokinetik von Ampizillin. Zentralbl Gynakol 1978 100 : 701 5.
25. Philipson A. Pharmacokinetics of ampicillin during pregnancy. J Infect Dis 1977 136 : 370 6.
26. Chamberlain A, White S, Bawdon R, Thomas S, Larsen B. Pharmacokinetics of ampicillin and sulbactam in pregnancy. Am J Obstet Gynecol 1993 168 : 667 73.
27. Bloom SL, Cox SM, Bawdon RE, Gilstrap LC. Ampicillin for neonatal group B streptococcal prophylaxis: how rapidly can bactericidal concentrations be achieved? Am J Obstet Gynecol 1996 175 : 974 6.
28. Adamkin DH, Marshall E, Weiner LB. The placental transfer of ampicillin. Am J Perinatol 1984 1 : 310 1.
29. Lovering AM, Pycock CJ, Harvey JE, Reeves DS. The pharmacokinetics and sputum penetration of ampicillin and amoxycillin following simultaneous i.v. administration. J Antimicrob Chemother 1990 25 : 385 92.
30. Sjovall J, Westerlund D, Alvan G. Renal excretion of intravenously infused amoxycillin and ampicillin. Br J Clin Pharmacol 1985 19 : 191 201.
31. de Haan GJ, Edelbroek P, Segers J, Engelsman M, Lindhout D, Devile-Notschaele M, Augustijn P. Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study. Neurology 2004 63 : 571 3.
32. Andes D, Craig WA. Animal model pharmacokinetics and pharmacodynamics: a critical review. Int J Antimicrob Agents 2002 19 : 261 8.
33. Jacobs MR. Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters. Clin Microbiol Infect 2001 7 : 589 96.
34. de Hoog M, Mouton JW, van den Anker JN. New dosing strategies for antibacterial agents in the neonate. Semin Fetal Neonatal Med 2005 10 : 185 94.
35. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Clinical breakpoints and epidemiological cut-off values: Clinical breakpoints. Available at http://217.70.33.99/Eucast2/ (last accessed 23 March 2008).
36. Hoffler D The pharmacokinetics of amoxicillin Adv Clin Pharmacol 1974 7 : 28 30.
37. Sjovall J, Alvan G, Huitfeldt B. Intra- and inter-individual variation in pharmacokinetics of intravenously infused amoxycillin and ampicillin to elderly volunteers. Br J Clin Pharmacol 1986 21 : 171 81.
38. Frederiksen MC. Physiologic changes in pregnancy and their effect on drug disposition. Semin Perinatol 2001 25 : 120 3.
39. Fujitani S, Baldisseri MR. Hemodynamic assessment in a pregnant and peripartum patient. Crit Care Med 2005 33 (10 Suppl. S354 61.